Latest Period
Q4 2025
Security Snapshot
DNA X, Inc. - Common Stock, par value $0.001 per share (SONM) Institutional Ownership
CUSIP: 83548F309
13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$0.70
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- SONM on Nasdaq
- Shares outstanding
- 1,121,613
- Price per share
- $0.70
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 0
- Total reported value
- $0
- Share change
- -521,316
- Value change
- -$314,806
- Number of holders
- 0
- Price from insider filings
- $0.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- SONM - DNA X, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 83548F309.
- 0 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 13 to 0 between Q3 2025 and Q4 2025.
- Reported value moved from $314,819 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 83548F309?
CUSIP 83548F309 identifies SONM - DNA X, Inc. - Common Stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 83548F309:
Significant Owners of DNA X, Inc. - Common Stock, par value $0.001 per share (SONM) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| AJP Holding Company, LLC | 19% | 0% | $1,853,797 | 1,972,124 | 0% | Jeffrey Wang | 26 Jun 2025 | |
| Orbic North America LLC | 33% | $2,609,442 | 1,947,345 | Orbic North America, LLC. | 11 Mar 2025 | |||
| DNA Holdings Venture Inc. | 20% | $156,241 | 223,201 | DNA Holdings Venture Inc. | 15 Dec 2025 | |||
| LYTTON LAURENCE W | 10% | +27% | $103,803 | +$47,844 | 148,290 | +85% | LYTTON LAURENCE W | 31 Dec 2025 |
As of 31 Dec 2025, 0 institutional investors reported holding 0 shares of DNA X, Inc. - Common Stock, par value $0.001 per share (SONM). This represents 0% of the company’s total 1,121,613 outstanding shares.
Institutional Holders of DNA X, Inc. - Common Stock, par value $0.001 per share (SONM) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 0 | $0 | -$314,806 | $0.70 | 0 |
| 2025 Q3 | 521,337 | $314,819 | +$81,386 | $0.60 | 13 |
| 2025 Q2 | 238,785 | $291,698 | +$63,379 | $1.22 | 19 |
| 2025 Q1 | 125,519 | $268,621 | +$74,604 | $2.14 | 12 |
| 2024 Q4 | 89,964 | $283,849 | -$32,382 | $3.15 | 10 |
| 2024 Q3 | 100,534 | $291,056 | +$290,995 | $2.90 | 9 |